{
  "id": 15931889,
  "title": "Treasury expected to be harder on China biotech deals in new rules",
  "url": "https://urgent.news/2026/10/21/treasury-expected-to-be-harder-on-china-biotech-deals-in-new-rules",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-21T18:48:02.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/treasury-expected-to-be-harder-on-china-biotech-deals-in-new-rules/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The pharma industry is bracing for a more stringent assessment of China deals from the Treasury Department, despite months of work to escape a harsh clampdown on buying new assets there. Endpoints News spoke with ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}